<DOC>
	<DOCNO>NCT00951119</DOCNO>
	<brief_summary>Rationale : Hypertension important risk factor cardiovascular disease , especially patient type 2 diabetes mellitus ( T2DM ) . A relatively recent development treatment hypertension use breathing exercise . The investigator ' previous study breathe device show positive result . However , study trial investigate effect breathe device double-blind design . Therefore , investigator want perform randomize , double-blind , control trial population T2DM patient . Objective : To determine effect device slow breathing ( Resperate© ) office systolic blood pressure ( SBP ) diabetic patient treat hypertension moderate BP control . Study design : A randomized , double-blind , controlled trial . Study population : Patients type 2 diabetes mellitus , 18 year old baseline systolic blood pressure 140-160 mm Hg . Intervention : One group receive treatment breathe device ( Resperate© ) group receive treatment `` control '' breathe device . The latter device try alter breathe pattern . Main study parameters/endpoints : The effect breathe device SBP main study parameter . Secondary endpoint include diastolic blood pressure ( DBP ) quality life .</brief_summary>
	<brief_title>Device-guided Breathing Exercises Blood Pressure Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>know T2DM , 18 year old , know hypertension systolic BP ( SBP ) 130170 mm Hg previous visit internal outpatient department last visit internist ( day baseline measurement ) treat one antihypertensive drug , change precede three month . At baseline SBP 140160 mm Hg , measure investigator . patient orthostatic hypotension , know heart failure ( NYHA IIIIV ) and/or patient pulmonary disease ( example asthma , chronic obstructive pulmonary disease pulmonary fibrosis ) , patient insufficient knowledge Dutch language understand requirement study , additional criterion hospitalization past 3 month , deafness , blindness cognitive ability deem insufficient operation study device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>hypertension</keyword>
	<keyword>treatment</keyword>
	<keyword>non-medical</keyword>
</DOC>